Compare tickers
Up to 5 tickers, ~30 metrics, weighted verdict. Best in green, worst in red.
Verdict
Weighted score 0-100 across 1 tickers · best in green
25
25
15
20
15
Total: 100 · normalized in scoring
#1
ABBV
score 50.0
Forward PE of 13.3 dominates with exceptional value despite negative momentum dragging down overall rank with -7.89% three-month decline.
value 50growth 50quality 50momentum 50sentiment 50
ABBV
AbbVie Inc.
$215.40
+1.16%
ABBV
AbbVie Inc.
$215.40
+1.16%
Snapshot
Price
215.4
Day %
1.16
1M %
4.26
3M %
-7.89
YTD %
-6.07
Market cap
380567158784.0
ADV ($)
1431345883.4417725
Beta
0.305
Tao zone
Current zone
Neutral
Dist 21-EMA %
1.63
Dist ATR (σ)
0.64
Tao grade
C
Confluence
2
Valuation
P/E (ttm)
105.588234
P/E (fwd)
13.271906
P/S
6.0581536
EV/EBITDA
14.701
P/B
-57.18078
FCF yield
0.0547
PEG
0.59
Growth
Revenue yoy
0.124
EPS yoy
-0.462
FCF yoy
—
Quality
Gross margin
0.72026
Operating margin
0.32156
Net margin
0.05786
ROE
—
ROA
0.10032
Debt / Equity
—
Interest cov.
3.28
Technicals
RSI(14)
56.4
MACD signal
bull
vs 50-DMA
3.28
vs 200-DMA
-1.96
vs 52w high
-12.01
HV-30
23.3
Sentiment
Analyst rec
1.75
Target upside
17.41
Insider buy-sell 90d
—
Risk
Short interest
1.4199998999999999
Days to cover
3.39
Next earnings
2026-07-30
Full ABBV dashboard →